Black Cohosh: The Definitive Guide

What is black cohosh?

Black cohosh is Actaea racemosa (also called Cimicifuga racemosa), a North American plant whose root and rhizome are used in extracts. It is promoted mainly for hot flashes and other menopause symptoms. It is not blue cohosh, a different plant with different risks. [4]

The evidence does not reduce to “works” or “does not work.” A newer pooled analysis reports modest symptom signals, while a rigorous earlier review and large year-long trial found no placebo advantage. Extract, outcome and study selection change the conclusion. [1]–[3]

Typical Black Cohosh Protocols

There is no RDA, AI or established UL. Milligrams are not interchangeable across extracts.

Titration

No validated general self-titration is established.

Timing

No universal best clock time is established.

Duration

Trials lasted weeks to one year; they do not establish indefinite use.

Stopping

No standard taper; stop and seek review for liver-warning symptoms.

What is black cohosh commonly used for?

Black cohosh is commonly used for hot flashes, night sweats, sleep disruption and broader menopause symptoms. The 2023 analysis found signals for overall, hot-flash and somatic outcomes, but not anxiety or depression. Evidence for breast-cancer-treatment hot flashes and non-menopause uses remains insufficient. [1], [4]

Which form and label details matter?

1. Species and part: Actaea racemosa root/rhizome. Black and blue cohosh are different plants.
2. Solvent and ratio: ethanolic and isopropanolic extracts are not automatically equivalent.
3. Marker: note triterpene-glycoside standardization, while recognizing it does not prove the full identity.
4. Independent identity testing: adulteration with other Actaea species is a documented concern. [5]
5. Daily total: distinguish milligrams per tablet from the total across tablets.

What does the human evidence show?

Menopause symptoms

Sadahiro and colleagues pooled 22 articles with 2,310 menopausal women. Compared with placebo, black cohosh products were associated with overall symptom improvement (Hedges g 0.575, 95% CI 0.283–0.867), hot-flash improvement (g 0.315, 95% CI 0.107–0.524) and somatic improvement. Anxiety and depressive outcomes crossed no effect, and dropout odds were similar to placebo. The analysis included black cohosh alone and combination regimens, which limits transfer to a specific product. [1]

The 2012 Cochrane review included 16 trials and 2,027 participants using oral monopreparations. It found no significant placebo difference in hot-flush frequency (0.07 flushes/day, 95% CI −0.43 to 0.56) or menopause scores. Trial quality and reporting were uncertain. [2]

Large null trials

The HALT trial randomized 351 women to black cohosh 160 mg/day, multibotanicals, a soy-enhanced regimen, hormone therapy or placebo for one year. The herbal arms did not improve vasomotor frequency or intensity versus placebo at 3, 6 or 12 months. [3]

A separate 89-person trial found 34% reduction with black cohosh, 57% with red clover and 63% with placebo after 12 months; neither botanical significantly outperformed placebo. [6]

How might it work?

Triterpene glycosides, phenolic acids and other constituents are proposed contributors. The active constituent and clinical mechanism remain uncertain, and current evidence does not justify describing black cohosh simply as “natural estrogen.” Product composition changes with species and extraction. [4], [5]

What are the risks and interactions?

Gastrointestinal upset and rash are the most common mild effects. Reports of liver injury, including severe cases, exist, but attribution is uncertain and some products may have been adulterated or mislabeled. That uncertainty supports symptom-based caution rather than a claim that injury is either proven common or impossible. [4], [5]

Avoid use during pregnancy or breastfeeding. Safety after hormone-sensitive cancer is uncertain; oncology review is important. Review medicines and existing liver disease with a clinician because interaction studies and long-term safety are incomplete. [4]

Seek urgent care for jaundice, dark urine, pale stool, severe abdominal pain, marked unexplained fatigue, facial swelling or breathing difficulty.

Legal status in the United States and Canada

In the United States, black cohosh supplements are not FDA-approved treatments for menopause symptoms.

In Canada, licensed natural health products carry an NPN and product-specific label conditions. An NPN does not establish equivalence across species, extracts or combinations.

What should you monitor?

Record the Latin species, plant part, extraction solvent, standardization, amount per unit, daily total, start date, medicines and symptoms. Use a consistent daily hot-flash count and severity scale. Record possible liver symptoms rather than waiting for a scheduled check-in.

What happens when you stop?

A predictable withdrawal syndrome and evidence-based taper are not established. Symptoms may return to their untreated pattern. Stop promptly and obtain medical review if liver-injury symptoms develop.

How should it be stored?

Keep the product sealed, dry, away from heat and out of children's reach. Do not use products with unclear species, damaged seals or unexpected changes in appearance or odor.

How does black cohosh compare with other approaches?

Black cohosh is not menopausal hormone therapy, an SSRI/SNRI, gabapentin or an approved nonhormonal menopause medicine. Those options have different evidence, contraindications and monitoring. Red clover supplies isoflavones and has a different mechanism and evidence base.

What do public communities add?

Public reports can flag taste, gastrointestinal effects, rash, perceived hot-flash changes and label confusion. They cannot authenticate Actaea racemosa, detect liver injury or separate treatment effects from the large placebo response seen in trials.

Common questions

Does black cohosh reduce hot flashes?

The 2023 pooled analysis found a modest signal, but major earlier analyses and large trials were null. Product and study selection matter. [1]–[3]

Is it estrogen?

No. It is a botanical extract, and its active mechanism is uncertain.

Is 40 mg the best dose?

No. It was the median exposure across heterogeneous trials, not a universal optimum. [2]

Can it be used after breast cancer?

Safety and efficacy in hormone-sensitive conditions remain uncertain. Involve the oncology team. [4]

Can it harm the liver?

Rare serious reports exist, but causality and product identity are uncertain. Liver-warning symptoms still need prompt care. [4]

Are black cohosh and blue cohosh the same?

No. They are different plants; blue cohosh has different and potentially serious risks. [4]

Is it safe during pregnancy?

No reliable safety basis supports use during pregnancy or breastfeeding. [4]

Should it be cycled?

No evidence-based on/off cycling schedule is established.

Glossary

Terms used in this guide.

Vasomotor symptoms

Hot flashes and night sweats related to temperature-regulation changes.

Hedges g

A standardized effect-size measure adjusted for small samples.

Monopreparation

A product containing black cohosh without other active botanicals.

Rhizome

An underground stem; black cohosh supplements use root and rhizome.

Adulteration

Substitution, contamination or undeclared mixing that changes product identity.

Titration

Changing an amount in planned steps. No general black-cohosh self-titration is established.

How this guide was researched

This draft prioritized the 2023 meta-analysis, Cochrane review, HALT and Geller trials, the current NCCIH fact sheet and a botanical identity study. Searches separated monopreparations, mixtures, outcomes and extracts.

Corrections narrow menopause claims, keep null trials visible and strengthen product-identity and liver-warning guidance. Evidence was refreshed October 9, 2026.

How this guide was made

The source ledger records preparation, population, schedule, outcome and access level.

Sources

Related guides